| abstract |
PCT No. PCT/JP96/01438 Sec. 371 Date Oct. 10, 1997 Sec. 102(e) Date Oct. 10, 1997 PCT Filed May 29, 1996 PCT Pub. No. WO96/38173 PCT Pub. Date Dec. 5, 1996The present invention relates to a composition for treating or preventing brain edemas which comprises containing an endothelin antagonist as an active ingredient, for example, the compound of the following formula (I): or pharmaceutically acceptable salts or hydrates thereof, bosentan, cyclo[D-aspartyl-L-[3-(4-phenylpiperazin-1-ylcarbonyl)]-alanyl-L-aspartyl-D-[2-(2-thienyl)]glycyl-L-leucyl-D-tryptophyl]disodium or cyclo [D-Asp-L-Pro-D-Val-L-Leu-D-Trp]. Furthermore, the present invention provides a method for treating or preventing brain edemas, which comprises administering an effective amount of an endothelin antagonist and use of an endothelin antagonist for the manufacture of a medicament for treating or preventing brain edemas. An endothelin antagonist exhibits an inhibitory effect, on all brain edemas regardless of the onset mechanism and thus is highly useful in the treatment or prevention of brain edemas. |